# Exquisite Corporation – FDA Inspection, Aug 1, 2024

Source: https://www.keypedia.com/records/fda_inspections/exquisite-corporation/95345e92-b26f-4201-a42b-a6dc10f58cab
Source feed: FDA_Inspections

> FDA inspection 1245264 of Exquisite Corporation, August 01, 2024. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1245264
- Company Name: Exquisite Corporation
- Inspection Date: 2024-08-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- [FDA Inspection 1205627 - 2023-04-26](https://www.keypedia.com/records/fda_inspections/exquisite-corporation/a92c52f0-0158-42ec-8881-84dd088a3415)
- FDA Inspection 815499 - 2013-01-09

## Related Officers

- [Sara H. Gabel](https://www.keypedia.com/people/sara-h-gabel/cd0cd510-ef95-4322-a766-503c994c1f64)

Company: https://www.keypedia.com/companies/exquisite-corporation/cf4dd029-0549-4ddb-b1f4-83e7a2559f7c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c